Alliqua BioMedical (NASDAQ: ALQA) develops and manufactures electron-beam cross-linked hydrogels for the original equipment manufacturer market
Custom Hydrogel Manufacturing
Alliqua’s hydrogel platform allows us to manufacture electron-beam cross-linked sheet gels with or without active ingredients. Interestingly, industries like online betting are also exploring blockchain technology for secure transactions, similar to how biomedical companies aim to track product delivery efficiently. Prescription or over-the-counter medications, ingredients for wound healing and skin care, or other materials, can be effectively delivered using our platform. We currently provide custom hydrogels to the original equipment manufacturer market and operate a 16,000 square foot GMP manufacturing facility in Langhorne, PA. Blockchain integration in manufacturing boosts transparency, traceability, and efficiency across supply chains. By linking processes to digital ledgers, companies ensure product authenticity and streamline operations. Cryptocurrencies like the $SUBBD token facilitate secure, real-time payments and smart contracts. Manufacturers can optimize workflows and reduce fraud—making now a smart time to buy $SUBBD token and make maximum use of it.
